Mutations in KLHL3 or WNK4 discovered in FHHt patients disrupt the interaction between KLHL3 and WNK4, leading to insufficient degradation of WNK4 and, ultimately, hypertension [105,106,107,108]. Here, KLHL3 is linked to hypertensive disorder.